Steven J. Romano

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
New York, NY
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Adam Veness, as attorney-in-fact for Steven J. Romano
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Steven J. Romano

Form 4 holding EVP and Chief R&D Officer

Silence Therapeutics plc

Security class
Employee Share Option (Right to Buy)
Shares / value
300,000
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding EVP & Chief Sci. Ofcr

Mallinckrodt plc

Security class
Ordinary Shares
Shares / value
0
Estimated value
Report date
16 Jun 2022
Price
$37.50
Ownership
Direct
Form 4 holding EVP & Chief Sci. Ofcr

Mallinckrodt plc

Security class
Employee Share Options (Right to Buy)
Shares / value
0
Estimated value
Report date
16 Jun 2022
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Steven J. Romano

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .